<DOC>
	<DOC>NCT02385656</DOC>
	<brief_summary>Open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients.</brief_summary>
	<brief_title>The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study</brief_title>
	<detailed_description>This is an open-pilot study for the efficacy and tolerability of modafinil on the fatigue and somnolence in cancer-patients. Patients with moderate to severe cancer-related fatigue will be treated with modafinil for 4 weeks and psychological tests including self-questionnaire, cognitive test, sleep-wake cycle, quantitative electroencephalogram(QEEG) will be applied pre- and post-treatment.</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<criteria>solid cancer patient age of 2065 years old subjects who scored =4 or &gt;4 on the Brief Fatigue Inventory subjects with informed consent metastatic cancer(stage IV) with psychotic symptoms such as delusion and hallucination or with suicidal risk with delirium or dementia current medication of cognitive enhancer or psychostimulant uncontrolled medical illness current medications that are contraindicated or not recommended for coadministration with modafinil</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>